TrialDigestive diseases and sciences2018

Assessment of Serum sTREM-1 as a Marker of Subclinical Inflammation in Diarrhea-Predominant Patients with Irritable Bowel Syndrome.

Chao Du et al.PubMed ↗Publisher ↗

No numbers read from the abstract.